Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Paraskevi Vogiatzi
Pharmacologic Suppression of JAK1/2 by JAK1/2 Inhibitor AZD1480 Potently Inhibits IL-6-Induced Experimental Prostate Cancer Metastases Formation
Molecular Cancer Therapeutics
Cancer Research
Oncology
Following the Tracks of AKT1 Gene
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Related publications
FRI0428 the JAK1-selective Inhibitor, Filgotinib, Inhibits Inflammation Pathways Observed in an IL23-induced Psoriatic Arthritis Mouse Model
Human Dendritic Cells Mitigate NK-Cell Dysfunction Mediated by Nonselective JAK1/2 Blockade
Cancer immunology research
Cancer Research
Immunology
Repurposed JAK1/JAK2 Inhibitor Reverses Established Autoimmune Insulitis in NOD Mice
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
IL-6 Inhibits Starvation-Induced Autophagy via the STAT3/Bcl-2 Signaling Pathway
Scientific Reports
Multidisciplinary
Role of the IL-6-JAK1-STAT3-Oct-4 Pathway in the Conversion of Non-Stem Cancer Cells Into Cancer Stem-Like Cells
Cellular Signalling
Cell Biology
Matrine Increases the Inhibitory Effects of Afatinib on H1975 Cells via the IL-6/JAK1/STAT3 Signaling Pathway
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Effect of COX-2 (PGE2) and IL-6 on Prostate Cancer Bone Mets
HOXA10 Deteriorates Gastric Cancer Through Activating JAK1/STAT3 Signaling Pathway
Cancer Management and Research
Oncology
Thymic Stromal Lymphopoietin-Mediated STAT5 Phosphorylation via Kinases JAK1 and JAK2 Reveals a Key Difference From IL-7-induced Signaling
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
